Test Price
4,500 AED✅ Home Collection Available
Spinocerebellar Ataxia (SCA) Extended Profile Test in UAE | 4500 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Spinocerebellar Ataxia (SCA) Extended Profile is a definitive genetic assay that detects pathogenic trinucleotide repeat expansions across the most clinically relevant SCA genes (SCA1, 2, 3, 6, 7, 8, 10, 12, 17, and DRPLA). Using a single 4 mL EDTA whole blood sample, this test enables neurologists to confirm a molecular diagnosis for hereditary ataxia with exceptional speed and accuracy, guiding prognosis and family planning. The methodology employs Triplet-Primed PCR (TP-PCR) with capillary electrophoresis fragment analysis, providing 100% capture of all common SCA repeat expansion loci.
| Feature | Our SCA Extended Profile | Whole Exome Sequencing (Alternative) |
|---|---|---|
| Detection Method | Triplet-Primed PCR (TP-PCR) with Capillary Electrophoresis Fragment Analysis | Next-Generation Sequencing (NGS) |
| Target | Repeat-expansion mutations with 100% capture for all common SCA loci | Broad exome; may miss large repeat expansions due to read-length limitations |
| Turnaround Time | 5 working days (sample Tuesday, report Saturday) | 3–6 weeks |
| Diagnostic Sensitivity | 99.9% for SCA repeat expansions | Variable; often <10% for large STRs without dedicated bioinformatics |
| ICD-10 Assignment | G11.8, G11.1, G11.2 | R27.0 (often non-specific) |
Physician Insight & Safety Protocols
“The SCA Extended Profile delivers a molecularly precise diagnosis by identifying the exact trinucleotide repeat expansion subtype. This allows clinicians to differentiate between ataxia syndromes that present with overlapping clinical features. I recommend correlating every genetic finding with a full neurological examination and a structured pedigree analysis before making treatment or counselling decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory Notice – Medication & Clinical Context
⚠ Medication Advisory
This genetic test provides diagnostic information to guide clinical management. Do not stop, start, or modify any prescribed therapy solely based on this report without consulting your treating physician. The test does not replace urgent medical assessment or ongoing treatment decisions.
Exclusion Criteria & Emergency Red Flags
- Recent blood transfusion (within 2 weeks) may interfere with DNA quality; please inform our team if applicable.
- This test is not a substitute for urgent neurological evaluation. If you experience sudden severe imbalance, difficulty swallowing, choking, or respiratory distress, seek emergency medical attention immediately.
- For minors, parental or legal guardian consent is mandatory in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the Spinocerebellar Ataxia Extended Profile test?
The SCA Extended Profile is a genetic blood test that detects abnormal CAG trinucleotide repeat expansions in multiple SCA genes, diagnosing hereditary ataxia subtypes with 99.9% sensitivity. By analyzing specific SCA loci (SCA1, 2, 3, 6, 7, 8, 10, 12, 17, and DRPLA), the report identifies the exact genetic cause of ataxia, enabling neurologists to stage the disease and offer targeted genetic counseling. The test requires only a 4 mL EDTA whole blood sample and uses Triplet-Primed PCR with capillary fragment analysis, the gold standard for repeat disorders.
2. How do I prepare for the SCA Extended Profile test?
No fasting or special preparation is required; simply ensure the mandatory Genomics Clinical Information Requisition Form (Form 20) is completed in full before sample collection. Our DHA-licensed mobile phlebotomist will collect 4 mL of whole blood in a lavender-top EDTA tube from your home or office. The sample is shipped refrigerated under ISO-certified cold-chain logistics to our molecular genetics laboratory, and you may resume all normal activities immediately afterwards.
3. Is the SCA Extended Profile test suitable for children?
Yes, this can be performed on children of any age under parental or legal guardian consent, strictly in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. A pediatric neurologist referral is recommended to interpret results in the context of developmental milestones and family history. In symptomatic children, early genetic confirmation can guide therapy, school support, and future planning. Results remain fully confidential under the UAE Personal Data Protection Law (PDPL).
4. How long does it take to receive results?
Results are available within 5 working days from sample collection. Our team will contact you by phone and secure email once the report is ready. A telephonic post-test clinical guidance session is included to help you and your referring physician understand the findings and next steps.
5. Will insurance cover the cost of this test?
We offer direct billing verification with most major UAE insurers. Send a copy of your insurance card via WhatsApp to +971 54 548 8731 and our billing team will confirm your coverage within 24 hours. The list price is 4500 AED inclusive of the collection, analysis, and clinical guidance.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection: This service is provided under DHA Facility License No. 1143 and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed exclusively within UAE-approved secure servers. ISO 9001:2015 certified laboratory processes ensure the highest standards of quality and confidentiality. Results are shared only with the ordering physician and the patient or legal guardian.
Clinical & Logistical Metadata
| Test Name | Spinocerebellar Ataxia (SCA) Extended Profile |
| Price (AED) | 4,500 AED |
| Turnaround Time | 5 working days |
| Sample Type / Matrix | 4 mL EDTA Whole Blood (Lavender-top tube) |
| Methodology Used | Triplet-Primed PCR (TP-PCR) with Capillary Electrophoresis Fragment Analysis |
| ICD-10-CM Code | G11.8, G11.1, G11.2 |
| LOINC Code | 94308-8 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians